IN-DATE
5397190: Bard GlidePath LT Hemodialysis Catheter, Straight, Exchange 14.5F / 19cm / 24cm, Preloaded
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $200.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 1 eaches |
| Expiration: | 11-2026 |
Additional Details
BD Bard GlidePath™ Long-Term Hemodialysis Catheters
LT: Long-Term Hemodialysis Catheters
Features
- Tip Style: Symmetric
- Exceptional performance
- Smooth tapered tip
- Tip designed to resist positional occlusion
- Improved inner lumen design
- Ease of placement
- AirGuard® Valved Introducer
- GlidePath™ Long-Term Hemodialysis Catheters demonstrate high flow rates & low pressure performance due to its improved inner lumen design.
Ease of Placement
- One Pre-Loaded Stylet to Simplify Over-the-Wire Placement (Straight Codes Only)
- Smooth Tapered Tip and Tapered Cuff for Easy Insertion
- AirGuard® Valved Introducer Reduces Risk of Air Embolism
AccessGUDID Info
- FDA Product Code: MSD
- FDA Product Code Name: Catheter, hemodialysis, implanted
- GMDN Term Code: 37278
- GMDN Term Name: Double-lumen haemodialysis catheter, implantable
- GMDN Term Description: An implantable, flexible, double-lumen tube intended to be used for chronic or long-term (> 30 days) vascular access, primarily during haemodialysis, to conduct blood from a patient and returning it after extracorporeal circulation; it may also be used during haemoperfusion and/or apheresis. It is intended for coaxial flow of blood, may be radiopaque, coated with heparin to prevent thrombus formation, and/or include a silver-coated sleeve to retard bacterial growth; devices dedicated to catheter introduction/function (e.g., introducer needle) may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
